XCR1 conventional dendritic cell-induced CD4 T helper 1 cell activation exacerbates cardiac remodeling after ischemic myocardial injury.

Cardiac remodeling has no established therapies targeting inflammation. CD4 T-cell subsets have been reported to play significant roles in healing process after ischemic myocardial injury, but their detailed mechanisms of activation remain unknown. To explore immune reactions during cardiac remodeling, we applied a non-surgical model of coronary heart disease (CHD) induced by a high-fat diet (HFD-CHD) in SR-BI/ApoeR61 mice. Flow cytometry analyses throughout the period of progressive cardiac dysfunction revealed that CD4 T Helper 1 (Th1) cells were predominantly activated in T-cell subsets. Probucol was reported to attenuate cardiac dysfunction after coronary artery ligation model (ligation-MI) in rats. To determine whether probucol suppress cardiac remodeling after HFD-CHD, we treated SR-BI/ApoeR61 mice with probucol. We found treatment with probucol in HFD-CHD mice reduced cardiac dysfunction, with attenuated activation of Th1 cells. RNA-seq analyses revealed that probucol suppressed the expression of CXCR3, a Th1-related chemokine receptor, in the heart. XCR1 cDC1 cells, which highly expresses the CXCR3 ligands CXCL9 and CXCL10, were predominantly activated after HFD-CHD. XCR1 cDC1 lineage skewing of pre-DC progenitors was observed in bone marrow, with subsequent systemic expansion of XCR1 cDC1 cells after HFD-CHD. Activation of CXCR3 Th1 cell and XCR1 cDC1 cells was also observed in ligation-MI. Notably, post-MI depletion of XCR1 cDC1 cells suppressed CXCR3 Th1 cell activation and prevented cardiac dysfunction. In patient autopsy samples, CXCR3 Th1 and XCR1 cDC1 cells infiltrated the infarcted area. In this study, we identified a critical role of XCR1 cDC1-activated CXCR3 Th1 cells in ischemic cardiac remodeling.